Is hydroxyurea leukemogenic in children with sickle cell disease?

被引：25

作者：

de Montalembert, M ^{[1
]}

Davies, SC ^{[1
]}

机构：

[1] Hop Necker Enfants Malad, Serv Pediat Gen, Paris, France

来源：

BLOOD | 2001年 / 98卷 / 09期

关键词：

D O I：

10.1182/blood.V98.9.2878

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2878 / 2879

页数：2

共 10 条

[1]

DAVIES SC, 1999, HAEMATOLOGY, V84

[2] Preliminary report of a toxicity study of hydroxyurea in sickle cell disease [J].

de Montalembert, M ;

Bégué, P ;

Bernaudin, F ;

Thuret, I ;

Bachir, D ;

Micheau, M .

ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (05) :437-439

[3] Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease [J].

deMontalembert, M ;

Belloy, M ;

Bernaudin, F ;

Gouraud, F ;

Capdeville, R ;

Mardini, R ;

Philippe, N ;

Jais, JP ;

Bardakdjian, J ;

Ducrocq, R ;

MaierRedelsperger, M ;

Elion, J ;

Labie, D ;

Girot, R .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (04) :313-318

[4] Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial [J].

Ferster, A ;

Vermylen, C ;

Cornu, G ;

Buyse, M ;

Corazza, F ;

Devalck, C ;

Fondu, P ;

Toppet, M ;

Sariban, E .

BLOOD, 1996, 88 (06) :1960-1964

[5] Five years of experience with hydroxyurea in children and young adults with sickle cell disease [J].

Ferster, A ;

Tahriri, P ;

Vermylen, C ;

Sturbois, G ;

Corazza, F ;

Fondu, P ;

Devalck, C ;

Dresse, MF ;

Feremans, W ;

Hunninck, K ;

Toppet, M ;

Philippet, P ;

Van Geet, C ;

Sariban, E .

BLOOD, 2001, 97 (11) :3628-3632

[6]

Kinney TR, 1999, BLOOD, V94, P1550

[7] Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years [J].

Najean, Y ;

Rain, JD .

BLOOD, 1997, 90 (09) :3370-3377

[8]

Rauch A, 1999, BLOOD, V94, p415A

[9] Hydroxyurea therapy in children severely affected with sickle cell disease [J].

Scott, JP ;

Hillery, CA ;

Brown, ER ;

Misiewicz, V ;

Labotka, RJ .

JOURNAL OF PEDIATRICS, 1996, 128 (06) :820-828

[10] Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea:: High proportion of cases with 17p deletion [J].

Sterkers, Y ;

Preudhomme, C ;

Laï, JL ;

Demory, JL ;

Caulier, MT ;

Wattel, E ;

Bordessoule, D ;

Bauters, F ;

Fenaux, P .

BLOOD, 1998, 91 (02) :616-622

← 1 →